24 completed, 17 recruiting, 4 active not recruiting, 4 terminated. 18 Phase 2, 13 Phase 1, 8 Not applicable, 6 Phase 3, 4 Early Phase 1.
Follow Positron Emission Tomography (PET): new trials by email Literature Review of Positron Emission Tomography (PET) trials Research Report on Positron Emission Tomography (PET)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Neuronavigation-guided FUS-induced BBB Opening in Alzheimer's Disease Patients and Its Effects on Brain Amyloid and Tau Neuronavigation-guided single-element focused ultrasound transducer, Lumason, Magnetic Resonance Imaging (MRI) with or without gadolinium contrast agents - Alzheimer Disease, Early Onset | Phase 1 | Not yet recruiting | Columbia University | 6 | 2027-08-01 | 2026-05-13 |
| Epcoritamab in Combination With R-CHOP for Patients With Aggressive Non-Hodgkin Lymphoma Rituximab, Cyclophosphamide, Hydroxydaunorubicin, Oncovin, Prednisolone (R-CHOP), Epcoritamab, Dexamethasone - Non-Hodgkin's B-cell Lymphoma, Lymphoma Non-Hodgkin | Phase 2 | Not yet recruiting | Carrie Ho, MD | 20 | 2026-11-15 | 2026-10-01 |
| Multi-organ Imaging of Microvascular and Metabolic Function 18F-FDG, Positron Emission Tomography (PET) - Healthy Subjects (HS), Cardiovascular Diseases (CVD) | Early Phase 1 | Not yet recruiting | Massachusetts General Hospital | 60 | 2026-07-01 | 2026-05-22 |
| Study Evaluating [18F]NOTA-ABY030 for Safety and Tolerability of Indeterminate Primary and/or Metastatic Disease in Head and Neck Squamous Cell Carcinoma Cetuximab (EGFR inhibitor), 18F-NOTA-ABY-030, Positron Emission Tomography (PET) - SCC - Squamous Cell Carcinoma, Radiotracer | Phase 1 | Recruiting | Vanderbilt-Ingram Cancer Center | 25 | 2026-04-24 | 2026-05-11 |
| A Cancer Vaccine (STEMVAC) in Combination With Chemotherapy for the Treatment of PD-L1 Negative Metastatic Triple-Negative Breast Cancer CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA Vaccine, Chemotherapy, Computed Tomography - Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Carcinoma | Phase 2 | Recruiting | University of Washington | 20 | 2026-03-24 | 2026-08-04 |
| Using FAPI PET/MRI to Evaluate Prostate Cancer FAPI, Positron Emission Tomography (PET), Magnetic Resonance Imaging - Prostate Cancer Metastatic Disease, Prostate Cancers | Phase 2 | Recruiting | University of Wisconsin, Madison | 30 | 2026-02-27 | 2026-06-10 |
| Flotufolastat F 18 PET in Men With Very Low PSA Recurrence Positron Emission Tomography (PET) - Prostate Cancer (Adenocarcinoma), Prostate Specific Antigen | Recruiting | Massachusetts General Hospital | 50 | 2025-05-20 | 2026-05-15 | |
| Enfortumab Vedotin and Pembrolizumab Combined With Radiotherapy in Muscle Invasive Bladder Cancer Enfortumab Vedotin, Pembrolizumab, Intensity Modulated Radiation Therapy (IMRT) - Bladder Cancer, Muscle-Invasive Bladder Carcinoma | Phase 1 / Phase 2 | Recruiting | University of California, San Francisco | 47 | 2025-03-31 | 2026-10-01 |
| Induction Chemotherapy Response-Guided Radiation for EBV-Associated Nasopharyngeal Carcinoma Intensity-Modulated Radiation Therapy (IMRT), Radiographic Imaging, Biospecimen Collection - Nasopharyngeal Carcinoma, Stage III Nasopharyngeal Carcinoma AJCC v8 | Not applicable | Recruiting | University of California, San Francisco | 66 | 2025-03-18 | 2026-06-17 |
| In Vivo Quantitative Mapping of Mitochondrial Cardiac Membrane Potential in Heart Failure Positron Emission Tomography (PET) - Mitochondrial Function | Active not recruiting | Matthieu Pelletier-Galarneau, MD MSc | 30 | 2024-11-25 | 2025-07-25 | |
| PET Imaging Study of 64Cu-GRIP B for Patients Receiving CD19-directed CAR-T Therapy 64Cu-GRIP B, Positron Emission Tomography (PET), Optional tumor biopsy - Non Hodgkin Lymphoma | Phase 1 | Recruiting | Michael Randall | 32 | 2024-10-23 | 2025-12-29 |
| Fluoroethyltyrosine for the Evaluation of Intracranial Neoplasm Fluorethyltyrosine (18-F), Positron Emission Tomography (PET) - Intracranial Neoplasm | Recruiting | Thomas Hope | 199 | 2024-06-21 | 2026-08-27 | |
| Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial Abiraterone, Apalutamide, Biospecimen Collection - Recurrent Castration-Sensitive Prostate Carcinoma, Recurrent Prostate Cancer | Phase 2 | Recruiting | Mayo Clinic | 532 | 2024-06-03 | 2026-07-20 |
| Investigating the Brain's Physiological Responses in Depression and Autism, Using Transcranial Magnetic Stimulation and Electroencephalography Positron Emission Tomography (PET), transcranial magnetic stimulation and electroencephalography(TMS-EEG) - Autism, Major Depressive Disorder (MDD) | Enrolling by invitation | National Taiwan University Hospital | 160 | 2024-05-28 | 2026-01-12 | |
| Mechanisms of Acute Kidney Injury in Severe Infections Positron emission tomography (PET) - Sepsis, AKI - Acute Kidney Injury | Recruiting | Uppsala University Hospital | 15 | 2024-05-01 | 2024-12-06 | |
| 64Cu-GRIP B in Patients With Advanced Malignancies Copper-64 labeled Granzyme B (64Cu-GRIP B), Positron Emission Tomography (PET) - Prostate Cancer, Renal Cancer | Phase 1 / Phase 2 | Recruiting | Rahul Aggarwal | 91 | 2023-05-25 | 2026-03-17 |
| Image-Based, In-Vivo Assessment of Tumor Hypoxia to Guide Hypoxia-Driven Adaptive Radiation Therapy Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET), 18F-fluoromisonidazole - Head and Neck Squamous Cell Carcinoma, Brain Metastases | Early Phase 1 | Recruiting | Vanderbilt-Ingram Cancer Center | 48 | 2023-05-17 | 2024-09-23 |
| Understanding New Cachexia Subtypes Through Observational Epidemiological Research Biospecimen Collection, Computed Tomography, Electronic health record review - Advanced Colorectal Carcinoma, Advanced Lung Non-Small Cell Carcinoma | Recruiting | Kaiser Permanente | 800 | 2023-04-05 | 2026-08-20 | |
| Acalabrutinib, Venetoclax and Durvalumab for the Treatment of Richter Transformation From Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Acalabrutinib, Durvalumab, Venetoclax - Chronic Lymphocytic Leukemia, Richter Syndrome | Phase 2 | Active not recruiting | Mayo Clinic | 27 | 2023-01-05 | 2026-10-05 |
| Detecting Early Alzheimer's Using MR Magnetic Resonance Imaging (MRI), Blood Glucose Assessment, Positron Emission Tomography (PET) - Alzheimer Disease | Recruiting | University of Aberdeen | 60 | 2022-11-15 | 2025-03-30 |
Showing 20 of 57. Sign in to see all of them.
Prostatic Neoplasms (9) · Alzheimer Disease (7) · Brain Neoplasms (4) · Lung Neoplasms (4) · Breast Neoplasms (2) · Carcinoma, Non-Small-Cell Lung (2) · Cognitive Dysfunction (2) · Colorectal Neoplasms (2) · Glioblastoma (2) · Hyperparathyroidism, Primary (2) · Kidney Neoplasms (2) · Lymphoma, Non-Hodgkin (2) · Neoplasms (2) · Squamous Cell Carcinoma of Head and Neck (2) · Acute Kidney Injury (1)
Thomas Hope (7) · University of California, San Francisco (6) · Stanford University (3) · Vanderbilt-Ingram Cancer Center (3) · Andrei Iagaru (2) · Columbia University (2) · Massachusetts General Hospital (2) · Mayo Clinic (2) · Rahul Aggarwal (2) · Alzheimer's Disease Cooperative Study (ADCS) (1) · Astellas Pharma Global Development, Inc. (1) · Carrie Ho, MD (1) · Centre Hospitalier Universitaire de Saint Etienne (1) · Chase Pharmaceuticals Corporation, an affiliate of Allergan plc (1) · City of Hope Medical Center (1)
United States (44) · Canada (4) · France (3) · Sweden (2) · United Kingdom (2) · China (1) · Finland (1) · Germany (1) · Italy (1) · Switzerland (1) · Taiwan (1)
Thomas Hope, MD (4) · Thomas A Hope, MD (3) · Andrei Iagaru (2) · Rahul Aggarwal, MD (2) · Ali Pirasteh, MD (1) · Andrei Iagaru, MD (1) · Brendan C Visser, MD (1) · Brie Chun, MD (1) · Cagri G. Besirli, MD PhD (1) · Carrie Ho, MD (1) · Chirayu Shah, MD (1) · Donald Podoloff, MD,BA (1) · Dr Andrew Quon (1)
PMID 20813339, PMID 21220675, PMID 21659625, PMID 22019547, PMID 22503160, PMID 22963265, PMID 27856630, PMID 30721110, PMID 32600374, PMID 32785820, PMID 33443618, PMID 33674398, PMID 34406051, PMID 34815790, PMID 35943235, PMID 36253968, PMID 36512649, PMID 36793451, PMID 37081528, PMID 37117993, PMID 37554284, PMID 39324520, PMID 39948600, PMID 40179327, PMID 41307953, PMID 41646720, PMID 42117295, PMID 42348024
1RC2AG036535 (1), 2015 (1), OT2CA278691 (1), P30CA033572 (1), P30CA068485 (1), P30CA124435 (1), P30CA138292 (1), R01AG038961 (1), R01CA229354 (1), R01CA258297 (1), R01CA286127 (1), R01CA300454 (1), U01AG024904 (1)